Theravance Respiratory Company, LLC (Tables)

3 Months Ended

Mar. 31, 2022

Theravance Respiratory Company, LLC

Summary financial information

	Three Months Ended
	March 31,
(In thousands)	2022		2021
Royalty revenue and gross profit	$	29,309	$	22,084
Income from continuing operations		29,112		18,803
Net income		29,541		18,320